Chief Financial Officer at TRX Biosciences Limited - Babraham, England, United Kingdom
TRX's technology enables targeted oral drug delivery to specific organs, cells and tissues in cancer, CNS and respiratory diseases and diseases of the immune system using a clinically and commercially proven approach.